📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Grifols

1.1 - Company Overview

Grifols Logo

Grifols

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of healthcare solutions operating in Bioscience, Hospital, and Diagnostic segments. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Grifols

Blade Therapeutics Logo

Blade Therapeutics

HQ: United States Website
  • Description: Provider of discovery-stage drug development focused on oral, small-molecule therapies for fibrotic and neurodegenerative diseases, including cudetaxestat—a Phase 2-ready, non-competitive autotaxin inhibitor for idiopathic pulmonary fibrosis; BLD-2184—an IND-ready candidate for neurodegenerative diseases; a class of autotaxin inhibitors; and calpain inhibitors targeting dimeric calpains.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Blade Therapeutics company profile →
Triveni Bio Logo

Triveni Bio

HQ: United States Website
  • Description: Provider of genetically informed functional antibody therapeutics for immunological and inflammatory disorders, supported by a proprietary data platform that leverages public and private datasets to identify therapeutic targets, predict patient subpopulations, and provide disease insights; lead program TRIV-509 targets kallikreins 5 and 7 for atopic dermatitis and other barrier disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Triveni Bio company profile →
iBio Logo

iBio

HQ: United States Website
  • Description: Provider of AI-driven drug discovery and antibody therapeutic development solutions, including a discovery platform to validate difficult targets and develop antibody therapeutics; patented Epitope Engineering Engine; fully human antibody library; StableHu Antibody Optimizer; EngageTx CD3 T-cell engager panel; and a pipeline of immuno-oncology and other therapeutic candidates.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full iBio company profile →
Forward Pharma Logo

Forward Pharma

HQ: Denmark Website
  • Description: Provider of biotechnology focused on the immunomodulatory compound dimethyl fumarate and derivatives for pharmaceutical drug applications to treat immune disorders such as multiple sclerosis and psoriasis; founded in 2005 and headquartered in Copenhagen, Denmark.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forward Pharma company profile →
ChemoCentryx Logo

ChemoCentryx

HQ: United States Website
  • Description: Provider of orally administered small-molecule therapeutics targeting chemokine and related chemo-attractant receptors for inflammatory and autoimmune diseases and cancer, focusing on the discovery, development and commercialization of new medications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ChemoCentryx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Grifols

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Grifols

2.2 - Growth funds investing in similar companies to Grifols

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Grifols

4.2 - Public trading comparable groups for Grifols

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Grifols

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Grifols

What does Grifols do?

Grifols is a provider of healthcare solutions operating in Bioscience, Hospital, and Diagnostic segments. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products.

Who are Grifols's competitors?

Grifols's competitors and similar companies include Blade Therapeutics, Triveni Bio, iBio, Forward Pharma, and ChemoCentryx.

Where is Grifols headquartered?

Grifols is headquartered in Spain.

How many employees does Grifols have?

Grifols has 1,000 employees 🔒.

When was Grifols founded?

Grifols was founded in 2010 🔒.

What sector and industry vertical is Grifols in?

Grifols is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Grifols

Who are the top strategic acquirers in Grifols's sector and industry

Top strategic M&A buyers and acquirers in Grifols's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Grifols?

Top strategic M&A buyers groups and sectors for Grifols include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Grifols's sector and industry vertical

Which are the top PE firms investing in Grifols's sector and industry vertical?

Top PE firms investing in Grifols's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Grifols's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Grifols's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Grifols's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Grifols include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Grifols's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Grifols?

The key public trading comparables and valuation benchmarks for Grifols include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Grifols for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Grifols with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Grifols's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Grifols with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Grifols's' sector and industry vertical?

Access recent funding rounds and capital raises in Grifols's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Grifols